Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index

Objectives: Sarcopenia is associated with a poor prognosis in the ICU. The purpose of this study was to describe a simple sarcopenia index using routinely available renal biomarkers and evaluate its association with muscle mass and patient outcomes. Design: A retrospective cohort study. Setting: A tertiary-care medical center. Patients: High-risk adult ICU patients from October 2008 to December 2010. Interventions: The gold standard for muscle mass was quantified with the paraspinal muscle surface area at the L4 vertebrae in the subset of individuals with an abdominal CT scan. Using Pearson’s correlation coefficient, serum creatinine-to-serum cystatin C ratio was found to be the best performer in the estimation of muscle mass. The relationship between sarcopenia index and hospital and 90-day mortality, and the length of mechanical ventilation was evaluated. Measurements and Main Results: Out of 226 enrolled patients, 123 (54%) were female, and 198 (87%) were white. Median (interquartile range) age, body mass index, and body surface area were 68 (57–77) years, 28 (24–34) kg/m2, and 1.9 (1.7–2.2) m2, respectively. The mean (± SD) Acute Physiology and Chronic Health Evaluation III was 70 (± 22). ICU, hospital, and 90-day mortality rates were 5%, 12%, and 20%, respectively. The correlation (r) between sarcopenia index and muscle mass was 0.62 and coefficient of determination (r 2) was 0.27 (p < 0.0001). After adjustment for Acute Physiology and Chronic Health Evaluation III, body surface area, and age, sarcopenia index was independently predictive of both hospital (p = 0.001) and 90-day mortality (p < 0.0001). Among the 131 patients on mechanical ventilator, the duration of mechanical ventilation was significantly lower on those with higher sarcopenia index (–1 d for each 10 unit of sarcopenia index [95% CI, –1.4 to –0.2; p = 0.006]). Conclusions: The sarcopenia index is a fair measure for muscle mass estimation among ICU patients and can modestly predict hospital and 90-day mortality among patients who do not have acute kidney injury at the time of measurement.

[1]  K. Tobe,et al.  Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study , 2015, The Journal of international medical research.

[2]  M. Englesbe,et al.  Implications of sarcopenia in major surgery. , 2015, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[3]  Joseph S. Hanna.  Sarcopenia and critical illness: a deadly combination in the elderly. , 2015, JPEN. Journal of parenteral and enteral nutrition.

[4]  S. Tarima,et al.  Sarcopenia and Frailty in Elderly Trauma Patients , 2015, World Journal of Surgery.

[5]  J. Lund,et al.  Simple psoas cross‐sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[6]  É. A. Silveira,et al.  Methods, Diagnostic Criteria, Cutoff Points, and Prevalence of Sarcopenia among Older People , 2014, TheScientificWorldJournal.

[7]  Patricia M Sheean,et al.  The prevalence of sarcopenia in patients with respiratory failure classified as normally nourished using computed tomography and subjective global assessment. , 2014, JPEN. Journal of parenteral and enteral nutrition.

[8]  L. Panton,et al.  Interrelationship among muscle, fat, and bone: Connecting the dots on cellular, hormonal, and whole body levels , 2014, Ageing Research Reviews.

[9]  Henrica C W de Vet,et al.  Nutrition screening tools: does one size fit all? A systematic review of screening tools for the hospital setting. , 2014, Clinical nutrition.

[10]  M. Shlipak,et al.  Update on cystatin C: incorporation into clinical practice. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  S. Boonen,et al.  Tools in the Assessment of Sarcopenia , 2013, Calcified Tissue International.

[12]  Azra Bihorac,et al.  Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury , 2013, Critical Care.

[13]  M. Morita,et al.  Creatinine/cystatin C ratio as a surrogate marker of residual muscle mass in amyotrophic lateral sclerosis , 2013 .

[14]  A. Day,et al.  Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool , 2011, Critical care.

[15]  Josef Coresh,et al.  Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  Jonathan Himmelfarb,et al.  Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. , 2009, Kidney international.

[17]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[18]  O. Gajic,et al.  Low baseline serum creatinine concentration predicts mortality in critically ill patients independent of body mass index* , 2007, Critical care medicine.

[19]  S. Tett,et al.  Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis. , 2007, Clinical biochemistry.

[20]  A. Shenkin.  Serum prealbumin: Is it a marker of nutritional status or of risk of malnutrition? , 2006, Clinical chemistry.

[21]  H. Koyama,et al.  Body fat mass and lean mass as predictors of survival in hemodialysis patients. , 2006, Kidney international.

[22]  Stanley Heshka,et al.  Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. , 2004, Journal of applied physiology.

[23]  N. Minamino,et al.  The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats. , 2004, Kidney international.

[24]  E. Erlandsen,et al.  Serum Cystatin C as an Endogenous Marker of the Renal Function – a Review , 1999, Clinical chemistry and laboratory medicine.

[25]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[26]  P. Angeli,et al.  Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. , 1994, Archives of internal medicine.

[27]  R. Jelliffe,et al.  Estimation of creatinine clearance from changing serum-creatinine levels. , 1971, Lancet.

[28]  T. Ikizler,et al.  Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  G. Gamba,et al.  Death Risk in CAPD Patients , 1993 .

[30]  N. Madias,et al.  Serum creatinine and renal function. , 1988, Annual review of medicine.

[31]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .